- Nachrichtendetail
-
21.05.2024 14:04:20 - dpa-AFX: *LILLY'S MIRIKIZUMAB SHOWS POSITIVE RESULTS: OVER HALF OF CROHN'S PATIENTS ACHIEVE REMISSION, EVEN AFTER BIOLOGIC FAILURE
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Eli Lilly & Co | 858560 | NYSE | 878,305 | 14.06.24 20:32:59 | -5,025 | -0,57% | 878,110 | 878,460 | 882,330 | 883,330 |
